SpaceX Stands Firm Amidst AI Selloff: Morgan Stanley's Bullish Outlook

Deep News11-18 14:12

During the recent turbulent AI selloff, SpaceX has demonstrated remarkable resilience against market declines. Morgan Stanley believes that SpaceX is decoupling from the traditional "AI trade," becoming a more durable safe haven in investor portfolios, maintaining its "Overweight" rating with a price target of $300.

According to reports from the trading desk, Morgan Stanley stated in a November 17 research note that SpaceX's core appeal lies in three major catalysts: the "bond-like" stable revenue characteristics displayed by its Starlink business, the massive capital expenditure plans of its subsidiary Terafab in reshaping the U.S. semiconductor supply chain (reaching $490 billion by 2035), and the currently highly attractive valuation level (2028 forward P/E far below the S&P 500 index).

However, the report also noted that the unresolved future relationship between SpaceX and Tesla remains the biggest uncertainty currently weighing on the stock price.

The "Bond-Like" Nature of the Core Business: Starlink's Astonishing Returns

As SpaceX's connectivity business (Starlink) revenue reaccelerates across retail, enterprise, and government markets, investors will rediscover the unique "bond-like" characteristics of this core business.

Morgan Stanley's calculations show that launching a fully loaded Starship with V3 broadband satellites (total capacity of 50 TBs, sellable capacity of 2.5 TBs), based on estimated 2030 run-rate projections, can generate approximately $300 million to $400 million in revenue, with an incremental EBIT payback period of only about 20 weeks.

Additionally, upcoming tests and accelerated space AI investments from non-SpaceX entities will further validate the value of space-based AI infrastructure.

Betting on "Tera'Merica": Massive Capital Expenditure to Reshape the U.S. Semiconductor Supply Chain

Against the backdrop of increasingly strict U.S. scrutiny over the outflow of cutting-edge AI semiconductor technology, the necessity for the U.S. to achieve wafer production self-sufficiency and semiconductor supply chain independence has never been higher. SpaceX/Terafab plays a potentially significant role in this process.

In Morgan Stanley's SpaceX model, Terafab has been allocated approximately $170 billion in capital expenditure through 2030, with capital expenditure reaching as high as $490 billion by 2035, including $15 billion in capital expenditure next year alone.

The current focus is on where these massive funds will specifically go and what investment returns they will bring to SpaceX shareholders.

The Biggest Question: The Future Relationship Between SpaceX and Tesla

Despite strong fundamentals, the biggest suppressing factor currently preventing the most optimistic investors from establishing or adding to positions is the uncertainty surrounding the future relationship between SpaceX and Tesla (including the final opinions of the independent committees of both companies' boards).

While most investors Morgan Stanley contacted generally acknowledge the value of a potential merger, they are concerned about the lack of certainty regarding merger timing and potential equity dilution risks.

Highly Attractive Valuation: Forward P/E Far Below the S&P 500

Currently, SpaceX trades at approximately $140 per share, only 4% above its IPO price of $135 per share. Since early July this year, Morgan Stanley's earnings per share (EPS) estimates for SpaceX in 2027 and 2028 have been significantly raised by 80% and 60%, respectively.

Excluding any tax benefits, SpaceX currently trades at 17.5 times Morgan Stanley's 2028 earnings estimates. This estimate is relatively conservative, assuming only 8.3 GW by the end of 2028 (compared to Musk's guidance of 13 GW by the end of 2027 and an estimated 14 GW by the end of 2028), and revenue per watt declining from $34 per watt in Q1 2027 to $21 per watt in fiscal 2028.

If using Visible Alpha's consensus estimates (excluding tax benefits), SpaceX's 2028 forward P/E is only 11.2 times. By comparison, the S&P 500 index currently has a 2028 forward P/E of 16 times, highlighting SpaceX's relatively low valuation.

Morgan Stanley's $300 price target is based on a sum-of-the-parts (SOTP) valuation method, specifically broken down as: Space business $8, Connectivity business $111, X & Grok $11, Enterprise AI $170.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment